NovaBridge Biosciences (NBP) Research & Development (2019 - 2025)

NovaBridge Biosciences (NBP) has 6 years of Research & Development data on file, last reported at $55.7 million in Q4 2025.

• Quarterly Research & Development rose 823.02% year-over-year to $55.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $62.9 million (up 747.84% YoY) and the FY2025 annual result came in at $62.9 million, up 188.95% from the prior year.
• Research & Development rose to $55.7 million in Q4 2025 per NBP's latest filing, from $11.3 million in the prior quarter.
• Across five years, Research & Development topped out at $55.7 million in Q4 2025 and bottomed at -$6.1 million in Q1 2024.
• The 4-year median for Research & Development is -$2.0 million (2025), against an average of $9.2 million.
• The widest annual swing landed in 2024, when Research & Development sank 82.64%; it then jumped 823.02% in 2025.
• Tracing NBP's Research & Development over 4 years: stood at $31.7 million in 2022, then rose by 9.67% to $34.7 million in 2023, then slumped by 82.64% to $6.0 million in 2024, then jumped by 823.02% to $55.7 million in 2025.
• Per Business Quant, the three latest NBP Research & Development figures stand at $55.7 million (Q4 2025), $11.3 million (Q3 2025), and -$3.3 million (Q2 2025).

Peer Comparison